5 Results for "

Caerulein

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "Caerulein" in MCE Product Catalog:

145
145 Publications Verification
Cat. No.: HY-A0190
CAS No.: 17650-98-5
Synonyms: Ceruletide; Cerulein; FI-6934
Caerulein is a decapeptide and a potent cholecystokinin receptor agonist. Caerulein is a safe and effective cholecystokinetic agent with a direct spasmogenic effect on the gallbladder muscle and bile ducts .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P1800A
Target:  

Peptides

Research Areas:  

Metabolic Disease

Caerulein, desulfated TFA is the desulfurated form of Caerulein. Caerulein is a decapeptide having the same five carboxyl-terminal amino acids as gastrin and cholecystokinin (CCK) .
loading...
    loading...
Cat. No.: HY-P1800
CAS No.: 20994-83-6
Research Areas:  

Metabolic Disease

Caerulein, desulfated is the desulfurated form of Caerulein. Caerulein is a decapeptide having the same five carboxyl-terminal amino acids as gastrin and cholecystokinin (CCK) .
loading...
    loading...
Cat. No.: HY-158722
CAS No.: 2760881-68-1
Caerulein acetate is a decapeptide and a potent cholecystokinin receptor agonist. Ceruletide acetate is a safe and effective cholecystokinetic agent with a direct spasmogenic effect on the gallbladder muscle and bile ducts .
loading...
    loading...
Cat. No.: HY-P5291
CAS No.: 103238-06-8
Synonyms: Caerulein precursor fragment
Target:  

Insulin Receptor

Research Areas:  

Metabolic Disease

CPF-7 (Caerulein precursor fragment) is an insulin-releasing peptide that stimulates the release of insulin. CPF-7 can induce epithelial-mesenchymal transition by upregulating Snai1 expression in PANC-1 ductal cells. CPF-7 also induces exocrine plasticity by upregulating Ngn3 expression. CPF-7 can be used in the research of type 2 diabetes .
loading...
    loading...